NBRDA Partners for Local Production of HIV Drugs in Nigeria
The National Biotechnology Research Development Agency (NBRDA) in Nigeria is collaborating with La Shipson Pharmaceuticals Ltd to begin local production of HIV drugs in the country. This move follows the signing of a Memorandum of Understanding (MoU) between the two organizations to enhance Nigeria's capacity for local medicine production.
The project, set to commence in the first quarter of 2026, aims to address the healthcare gap created by the withdrawal of international aid for HIV treatment. The collaboration is expected to not only improve access to affordable drugs but also create job opportunities, drive technology transfer, and upgrade the NBRDA laboratory's research capabilities.
Plus234Feed summary based on reporting from Nigerian Tribune. Read the original report below.
Read full article
Continue on Nigerian Tribune
Get the week in one email
Top stories, NPFL results, the naira — every Friday morning. Free, one email a week.
Related Stories
Nigeria Explores Innovative Tech to Boost Local Drug Production
Nigeria Secures Affordable HIV Prevention Drug Lenacapavir at UNGA80
NAFDAC Urges Pharma Firms to Invest in Vaccine Production for Health Security
Stakeholders Call for Local Financing to Fight HIV and TB in Nigeria
NBRDA Director General Affirms Safety of GMOs in Nigeria, Promotes Biotechnology Engagement
CSOs Push for Local Financing to Fight HIV and TB in Nigeria
Get Plus234Feed on messaging apps
Same headlines, delivered where you already scroll.
